PMID- 35859012
OWN - NLM
STAT- MEDLINE
DCOM- 20221129
LR  - 20240102
IS  - 1740-634X (Electronic)
IS  - 0893-133X (Print)
IS  - 0893-133X (Linking)
VI  - 48
IP  - 1
DP  - 2023 Jan
TI  - The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with 
      prolonged exposure therapy for posttraumatic stress disorder.
PG  - 255-256
LID - 10.1038/s41386-022-01381-7 [doi]
FAU - Rothbaum, Barbara O
AU  - Rothbaum BO
AUID- ORCID: 0000-0002-8793-7124
AD  - Emory University School of Medicine, Department of Psychiatry and Behavioral 
      Sciences, Atlanta, Georgia. brothba@emory.edu.
FAU - Maples-Keller, Jessica L
AU  - Maples-Keller JL
AUID- ORCID: 0000-0003-4768-7332
AD  - Emory University School of Medicine, Department of Psychiatry and Behavioral 
      Sciences, Atlanta, Georgia.
LA  - eng
GR  - P50 MH100023/MH/NIMH NIH HHS/United States
GR  - UL1 TR002378/TR/NCATS NIH HHS/United States
GR  - K12 HD085850/HD/NICHD NIH HHS/United States
PT  - News
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - England
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology : official publication of the American College of 
      Neuropsychopharmacology
JID - 8904907
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
RN  - 0 (Hallucinogens)
SB  - IM
MH  - Humans
MH  - *N-Methyl-3,4-methylenedioxyamphetamine/pharmacology
MH  - *Implosive Therapy
MH  - *Stress Disorders, Post-Traumatic/drug therapy
MH  - *Hallucinogens/therapeutic use
PMC - PMC9700782
COIS- BOR is a consultant to and owns equity in Virtually Better, Inc. that creates 
      virtual environments. The terms of these arrangements have been reviewed and 
      approved by Emory University in accordance with its conflict of interest 
      policies. JMK declares no competing interests.
EDAT- 2022/07/21 06:00
MHDA- 2022/11/30 06:00
PMCR- 2024/01/01
CRDT- 2022/07/20 23:48
PHST- 2022/07/21 06:00 [pubmed]
PHST- 2022/11/30 06:00 [medline]
PHST- 2022/07/20 23:48 [entrez]
PHST- 2024/01/01 00:00 [pmc-release]
AID - 10.1038/s41386-022-01381-7 [pii]
AID - 1381 [pii]
AID - 10.1038/s41386-022-01381-7 [doi]
PST - ppublish
SO  - Neuropsychopharmacology. 2023 Jan;48(1):255-256. doi: 10.1038/s41386-022-01381-7.